Woburn, Mass.-based Courtagen clinched a patent from the U.S. Patent and Trademark Office for the company’s Decontamination-Ready Encoded Amplification PCR device.
The device is used in clinical diagnostic assays for autism, epilepsy and mitochondrial disorders. It digests polymerase chain reaction products to eliminate the risk of contaminating DNA in clinical laboratory studies.
The patent concerns the device’s method of decontamination. — José Vasquez